Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models.
PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models. Clin Cancer Res. 2020 06 15; 26(12):3058-3070.
View in:
PubMed
subject areas
Animals
Animals
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Apoptosis
Cell Proliferation
Cell Proliferation
Cetuximab
Cetuximab
Disease Models, Animal
Disease Models, Animal
Female
Female
Head and Neck Neoplasms
Head and Neck Neoplasms
Humans
Humans
Mice
Mice
Mice, Nude
Mice, Nude
Phthalazines
Phthalazines
Piperazines
Piperazines
Poly(ADP-ribose) Polymerase Inhibitors
Poly(ADP-ribose) Polymerase Inhibitors
Prognosis
Prognosis
Smad4 Protein
Smad4 Protein
Tumor Cells, Cultured
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
Michael Carleton Rudolph